Bluebird bio Inc (NASDAQ:BLUE) price on Thursday, May 09,rose 14.92% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.12.
A look at the stock’s price movement, the close in the last trading session was $0.97. Turning to its 52-week performance, $5.53 and $0.85 were the 52-week high and 52-week low respectively. Overall, BLUE moved -5.88% over the past month.
Bluebird bio Inc’s market cap currently stands at around $215.87 million.
Turning to the stock’s technical picture we see that short term indicators suggest on average that BLUE is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
BLUE’s current price about 15.43% and -6.99% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 56.47, while 7-day volatility ratio is 13.43% and 9.97% in the 30-day chart. Further, Bluebird bio Inc (BLUE) has a beta value of 0.84, and an average true range (ATR) of 0.11.
If we refocus on Bluebird bio Inc (NASDAQ:BLUE), historical trading data shows that trading volumes averaged 8.23 million over the past 3 months. The company’s latest data on shares outstanding shows there are 192.74 million shares.
The 1.51% of Bluebird bio Inc’s shares are in the hands of company insiders while institutional holders own 61.66% of the company’s shares. Current price change has pushed the stock -18.84% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BLUE stock continues to rise going into the next quarter.